Aurora Cannabis Posts Q1 2022 Revenues Of $60.1 Million, Net Loss

Aurora Cannabis (TSX: ACB) last night released its first quarter financial results, posting revenues of $60.1 million. The firm also posted a net loss of $11.9 million for the three month period ended September 30, 2021.

Revenues for the quarter were up 10% on a quarter over quarter basis from $54.8 million, however results were still down on a year over year basis by 11%, with the firm posting $67.6 million in net revenues in the year ago period. The quarterly growth came from the medical cannabis segment, which saw revenues of $41.0 million, which was a 17% improvement from last quarter, and a 23% improvement from a year ago. Recreational cannabis however was down 44% year over year.

Following cost of sales of $33.4 million, the firm reported a gross profit of $26.7 million before fair value adjustments. Despite being three years into full legalization in Canada, this placed the firm nowhere near profitability, with operating expenses amounting to $64.8 million for the three month period.

Despite pushing the narrative of their transformation on track, selling, general and administrative expenses totaled out at $45.8 million, and increase of 4% from the $44.1 million recorded a year ago. The firm continues to guide towards $60 to $80 million in aggregate cost cutting across SG&A, production, facility and logistic expenses. Operationally, the firm lost $39.4 million in the three month period.

Things did not get a whole lot better from here, however the company did recognize positive other income of $27.3 million. This was largely lead by derivative liability gains under the other gains line item to the tune of $43.1 million, which was partially offset by $15.3 million in finance and other costs.

Overall, the company posted a net loss of $11.9 million for the quarter, while adjusted EBITDA came in at negative $12.1 million.

Moving to the balance sheet, the company saw its cash position fall from $421.4 million to $372.8 million, while restricted cash grew from $19.4 million to $51.5 million. Inventory also grew, climbing from $117.5 million to $137.4 million. Overall, total current assets fell from $665.9 million to $653.0 million.

Accounts payable also fell, dropping from $57.9 million to $54.6 million. This was offset however by convertible debentures, which moved from $34.7 million to $37.3 million. Total current liabilities overall climbed from $116.4 million to $120.4 million.

Aurora Cannabis last traded at $9.30 on the TSX.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Aurora Cannabis Reiterates Guidance For Q1 2021

Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning reiterated guidance for the first quarter of...

Friday, October 30, 2020, 08:21:19 AM

Aurora Cannabis Rallies On 316% Earnings Jump In Q3 2025

Aurora Cannabis (NASDAQ: ACB) saw its shares surge after releasing fiscal Q3 2025 results, with...

Sunday, February 9, 2025, 11:28:00 AM

Cronos Group Licenses IP From Aurora Cannabis, 22nd Century Group Related To Biosynthesis

Aurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ:...

Wednesday, December 15, 2021, 09:21:00 AM

BMO Struggling to Sell Aurora Cannabis’ TGOD Shares

Last night the Globe and Mail reported that a group of Investment Banks led by...

Friday, September 6, 2019, 12:24:09 AM

Aurora Cannabis: What Happened?

Terry Booth’s Thursday departure from the C suite at Aurora Cannabis (TSX: ACB) (NYSE: ACB)...

Sunday, February 9, 2020, 08:00:00 AM